Markets
← Back to Stocks
AMGN
AMGEN INC
Health Care · Biotechnology
$349.90
-0.42%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
CVS swap powers pre-market rally as Amgen gains 0.80% despite competitive pressures
Amgen traded up 0.80% to $380.02 in pre-market, gaining $3.02 from previous close of $377. The company declared a $2.52 per share dividend for Q2 2026 (announced March 4). However, CVS Health is swapping out Amgen and Eli Lilly's bone disease treatments for lower-cost alternatives starting April 1, presenting near-term headwinds.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$188.6B
P/E (TTM)24.6
Forward P/E15.0
Beta0.42
Div Yield287.00%
Prev Close$351.39
RSI (14-Day)
21Oversold
0305070100
52-Week Range
$261.43$349.90$391.29
From High-10.6%
From Low+33.8%
Moving Averages
50d SMA
$358.06-2.3%
200d SMA
$312.52+12.0%
Price between 50d and 200d. Testing 50d support.
Returns
1W
-4.9%
1M
-7.9%
3M
+7.8%
6M
+29.2%
1Y
+13.3%
YTD
+7.5%
Volume
Today53K
20d Avg2.5M
Ratio0.02x